Itra®

Itraconazole
Antifungals (Systemic Antifungal)

Indication:

Itra^® is used for the treatment of oropharyngeal candidiasis, vulvovaginal candidiasis, pityriasis versicolor, tinea pedis, tinea cruris, tinea corporis, tinea manuum, onychomycosis, histoplasmosis. It is indicated in the treatment of systemic candidiasis, aspergillosis, and cryptococcosis (including cryptococcal meningitis). It is also used for maintenance therapy in AIDS patients to prevent relapse of underlying fungal infections and in the prevention of fungal infection during prolonged neutropenia.

Dosage & Administration:

Oropharyngeal candidiasis: 100 mg daily (200 mg daily in AIDS or neutropenia) for 15 days. Vulvovaginal candidiasis: 200 mg twice daily for 1 day. Pityriasis versicolor: 200 mg daily for 7 days. Tinea corporis and tinea cruris: either 100 mg daily for 15 days or 200 mg daily for 7 days. Tinea pedis and tinea manuum: either 100 mg daily for 30 days or 200 mg twice daily for 7 days. Onychomycosis: either 200 mg daily for 3 months or course (pulse) of 200 mg twice daily for 7 days, subsequent courses repeated after 21 days’ interval. Fingernails two courses, toenails three courses. Systemic infections (aspergillosis, candidiasis and cryptococcosis including cryptococcal meningitis) where other antifungal drugs inappropriate or and in cryptococcal meningitis Histoplasmosis: 200 mg 1-2 times daily. Maintenance in AIDS patients to prevent relapse of underlying fungal infection and prophylaxis in neutropenia when standard therapy is inappropriate: 200 mg once daily, increased to 200 mg twice daily if low plasma Itraconazole concentration is detected. Child dose: the recommended dose is 3 to 5 mg/kg/day.

Preparation:

Itra^® 100 Capsule: Box containing 24 capsules in Alu-Alu blister.
Itra^® 200 Tablet: Box containing 18 tablets in Alu-Alu blister.